Plasma Fractionation Market Size, Share, and Forecast by 2028
Plasma Fractionation Market: Size and Share
-
CAGR (2021 - 2028)6.3% -
Market Size 2021
US$ 26.58 Billion -
Market Size 2028
US$ 40.73 Billion
Market Dynamics
- Rising need for plasma-based treatments
- Growing awareness of blood disorders
- Advances in protein fractionation
- Increase in the number of plasma-derived therapies
- Expansion in the global healthcare market
- Growth in blood plasma-based therapies
Market Segmentation
Product - Immunoglobulin
- Albumin
- Coagulation Factor Concentrates
- Protease Inhibitors
- Other Plasma Products
Application - Neurology
- Immunology
- Hematology
- Critical Care
- Pulmonology
- Other Applications
End User - Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Plasma Fractionation Market Players Density: Understanding Its Impact on Business Dynamics
The Plasma Fractionation Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Plasma Fractionation Market are:
- BASF SE
- TMIC
- Creative Proteomics
- BGI
- RTI International
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Plasma Fractionation Market top key players overview
Get Free Sample For